Clincosm LogoSign in Get a demo

SARS-CoV-2 Infection

Showing 26 - 50 of 247
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Active, not recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Feb 2, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Sumida-ku, Fukuoka (BNT162b2, Placebo)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Placebo
  • Sumida-ku, Tokyo, Japan
  • +1 more
Jan 13, 2023

SARS-CoV-2 Infection Trial in Germany, United States (PRIME-2-CoV_Beta)

Recruiting
  • SARS-CoV-2 Infection
  • Florida City, Florida
  • +6 more
Jan 31, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)

Active, not recruiting
  • SARS-CoV-2 Infection
  • VLA2001
  • Groningen, Netherlands
  • +3 more
Jan 17, 2023

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Recruiting
  • SARS-CoV-2 Infection
    • Aichi, Japan
    • +2 more
    Jan 17, 2023

    SARS-CoV-2 Infection in Hematologic Tumors

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Hematologic Malignancy
    • None intervention
    • Beijing, Beijing, China
      Peking University First Hospital
    Jan 13, 2023

    SARS-CoV-2 Infection Trial in Malaysia, Philippines (Azvudine, Placebo)

    Recruiting
    • SARS-CoV-2 Infection
    • Kuala Lumpur, Malaysia
    • +9 more
    Jan 5, 2023

    EuGeni Rapid Antigen Test for Qualitative Detection of Severe

    Terminated
    • SARS-CoV-2 Infection
    • EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
    • Split, Croatia
    • +4 more
    Jan 3, 2023

    SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

    Completed
    Has Results
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b2
    • Anaheim, California
    • +20 more
    Nov 30, 2022

    Sars-CoV-2 Infection Trial in Bydgoszcz (Evolocumab, Saline solution)

    Completed
    • Sars-CoV-2 Infection
    • Bydgoszcz, Poland
      Antoni Jurasz University Hospital No. 1
    Dec 14, 2022

    SARS-CoV-2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2)

    Completed
    • SARS-CoV-2 Infection
    • Recombinant NDV Vectored Vaccine for SARS-CoV-2
    • Mexico City, Ciudad De Mexico, Mexico
      Hospital Medica Sur
    Dec 8, 2022

    SARS-CoV-2 Infection Trial in Hohhot (Azvudine, Paxlovid group)

    Recruiting
    • SARS-CoV-2 Infection
    • Hohhot, Inner Mongolia, China
      Hohhot First Hospital
    Dec 7, 2022

    Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)

    Terminated
    • Covid19
    • SARS-COV-2 Infection
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Dec 4, 2022

    SARS-CoV-2 Infection Trial in United States (Moderna COVID-19 Vaccine)

    Completed
    • SARS-CoV-2 Infection
    • Moderna COVID-19 Vaccine
    • Birmingham, Alabama
    • +50 more
    Dec 1, 2022

    Sars-CoV-2 Infection, COVID-19 Trial in Madison (BinaxNOW Test, "Lollipop" swab)

    Enrolling by invitation
    • Sars-CoV-2 Infection
    • COVID-19
    • BinaxNOW Test
    • "Lollipop" swab
    • Madison, Wisconsin
      Community Locations
    Nov 30, 2022

    Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Imus, Makati City (PepGNP-COVID19 (One vaccination), Water for injection

    Not yet recruiting
    • Coronavirus
    • +2 more
    • PepGNP-COVID19 (One vaccination)
    • +3 more
    • Imus, Cavite, Philippines
    • +1 more
    Nov 30, 2022

    Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)

    Completed
    • Coronavirus
    • +2 more
    • LD Vehicle-GNP
    • +3 more
    • Lausanne, Vaud, Switzerland
      Center for Primary Care and Public Health (Unisante)
    Nov 28, 2022

    SARS-CoV-2 Infection, COVID-19 Recurrent, Cognitive Dysfunction Trial in Vigo, Ourense (COPERIA-REHAB)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +3 more
    • COPERIA-REHAB
    • Vigo, Pontevedra, Spain
    • +3 more
    Nov 28, 2022

    COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

    Completed
    • COVID-19
    • SARS-CoV-2 Infection
    • Quantitative analysis of SARS-CoV-2 antibodies
    • Cellular immunity
    • Prague, Czechia
      Institute of Health Information and Statistics of the Czech Repu
    Nov 25, 2022

    SARS-CoV-2 Infection Trial in Australia (ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001))

    Recruiting
    • SARS-CoV-2 Infection
    • ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001)
    • Kanwal, New South Wales, Australia
    • +5 more
    Nov 16, 2022

    SARS-CoV-2 Infection Trial in Aix-en-Provence (nasal spray)

    Terminated
    • SARS-CoV-2 Infection
    • nasal spray
    • Aix-en-Provence, France
      Dr Bouvier's Office
    Nov 14, 2022

    SARS-CoV-2 Infection Trial in Liverpool (Innova Lateral Flow Test)

    Completed
    • SARS-CoV-2 Infection
    • Innova Lateral Flow Test
    • Liverpool, United Kingdom
      Alder Hey Children's NHS Foundation Trust
    Nov 9, 2022

    Does Repeat Influenza Vaccination Constrain Influenza Immune

    Recruiting
    • Influenza, Human
    • SARS-CoV-2 Infection
    • Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
    • SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
    • New Lambton Heights, New South Wales, Australia
    • +5 more
    Nov 7, 2022

    SARS-CoV-2 Infection Trial in Canada, Sri Lanka (Nitric Oxide, Nasal spray with isotonic saline)

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Nitric Oxide
    • Nasal spray with isotonic saline
    • Oshawa, Ontario, Canada
    • +5 more
    Nov 3, 2022